DNM2 and focal segmental glomerulosclerosis: Because Adriamycin interferes with membrane proteins and podocyte cytoskeletal proteins and can thus impair podocyte function and albuminuria filtration and ultimately lead to glomerular sclerosis and renal failure, the AN model is the classic model of focal segmental glomerulosclerosis (Dou et al., 2020).